Bolt Biotherapeutics, Inc.
BOLT
$5.35
$0.081.52%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 52.93% | 59.61% | -2.12% | 10.99% | 6.65% |
| Total Depreciation and Amortization | -34.09% | -24.07% | -12.88% | -8.78% | -4.76% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -32.27% | -61.76% | -59.50% | 39.46% | -22.44% |
| Change in Net Operating Assets | -555.88% | -238.78% | 57.93% | -177.71% | 78.53% |
| Cash from Operations | 30.32% | 40.55% | 20.21% | -1.16% | 16.62% |
| Capital Expenditure | -75.61% | -- | -- | 100.00% | 75.15% |
| Sale of Property, Plant, and Equipment | -100.00% | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 5.43% | -40.05% | 33.18% | -22.66% | 32.82% |
| Cash from Investing | 4.35% | -40.05% | 42.61% | -22.63% | 35.39% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -82.28% | -- | -72.64% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -82.28% | -- | -72.64% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 157.00% | -37.63% | 118.11% | -231.45% | 177.54% |